Lovinger David M
Laboratory for Integrative Neuroscience, Division of Intramural Clinical and Basic Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA.
J Mol Neurosci. 2007 Sep;33(1):87-93. doi: 10.1007/s12031-007-0043-2.
Endocannabinoids are fatty acid derivatives that have a variety of biological actions, most notably via activation of the cannabinoid receptors. These receptors are also targets for drugs derived from Cannabis sativa. In the nervous system, endocannabinoids act as neuromodulators that depress neurotransmitter release at the presynaptic terminal. In most instances of neural endocannabinoid signaling, the compounds appear to be released from the postsynaptic neuron to act on the presynaptic terminal in a "retrograde" manner. Several common mechanisms involved in postsynaptic endocannabinoid production and presynaptic depression produced via activation of the CB1 cannabinoid receptor have been identified. However, significant problems remain in defining the mechanisms underlying endocannabinoid production, release, and movement across the membrane. These issues are discussed in the present review.
内源性大麻素是具有多种生物学作用的脂肪酸衍生物,最显著的是通过激活大麻素受体发挥作用。这些受体也是源自大麻的药物的作用靶点。在神经系统中,内源性大麻素作为神经调质,可抑制突触前终末的神经递质释放。在大多数神经内源性大麻素信号传导的情况下,这些化合物似乎从突触后神经元释放,以“逆行”方式作用于突触前终末。已经确定了几种参与突触后内源性大麻素产生以及通过激活CB1大麻素受体产生突触前抑制的常见机制。然而,在确定内源性大麻素产生、释放和跨膜移动的潜在机制方面仍存在重大问题。本综述将讨论这些问题。